We have taken great steps towards changing Teva profoundly, in a way that further highlights what makes us unique in this industry
“We are creating breakthroughs in neurodegeneration. Teva’s National Network of Excellence will contribute to the quality of life of us all.”
“Copaxone and Azilect came from Israeli universities. Why wouldn’t we tap into this incredible expertise and innovation of Israeli Universities to find the next jewels.”
"Our single-minded focus, through the skills of our scientists, is to ensure that we bring essential generic medicines of high quality to the greatest number of in the fastest time possible."
“Today we can understand the processes resultingin disease and response to drugs in individual patients with greater precision than ever before.”
“Our NTE process reflects our expertise ingenerics and specialty drugs, and the synergiescreated when these capabilities are integrated.”
"Our collaboration with Teva will contribute greatly to the Korean pharmaceutical industry by supplying innovative medicines at affordable prices."
“In China there is an increasing demand forquality generic medication. We were very impressedby Teva's oncology, CNS and respiratory portfolio."
“Our DNA is the combination of P&G and Teva. Our mission is to understand what people wantand need, and then find innovative ways to deliver that.”
“We are excited to develop environmentally friendly technologies to create a healthier world for our customers worldwide.“
All News › Top News May 12, 2016 Teva to Present New Data at the 2016 American Thoracic Society (ATS) International Conference Learn More Share Top News May 9, 2016 Teva to Present at the Bank of America Merrill Lynch 2016 Health Care Conference Learn More Share Top News May 9, 2016 Teva Reports First Quarter 2016 Results Learn More Share Top News May 4, 2016 Teva Breathes Its Way to a Guinness World Records Title Learn More Share Top News Apr 29, 2016 Teva Announces FDA Approval of ProAir RespiClick® (albuterol sulfate) Inhalation Powder for Pediatric Asthma Patients Ages 4 to 11 Learn More Share
Top News May 12, 2016 Teva to Present New Data at the 2016 American Thoracic Society (ATS) International Conference Learn More
Top News May 9, 2016 Teva to Present at the Bank of America Merrill Lynch 2016 Health Care Conference Learn More
Top News Apr 29, 2016 Teva Announces FDA Approval of ProAir RespiClick® (albuterol sulfate) Inhalation Powder for Pediatric Asthma Patients Ages 4 to 11 Learn More
Teva Germany Opts for 100% Renewable Energy Teva's German production sites will convert their electricity supplies to 100% renewable energy starting in December 2015. Discover more
Teva's German production sites will convert their electricity supplies to 100% renewable energy starting in December 2015.
TAPI Launches New Website! TAPI has launched a new website with an enhanced product catalogue. TAPI continues to deliver high-quality APIs and committed customer service. Discover more
TAPI has launched a new website with an enhanced product catalogue. TAPI continues to deliver high-quality APIs and committed customer service.
New Plant in Croatia Croatian Prime Minister Tihomir Orešković opens Teva's new multi-purpose synthesis plant in Savski Marof. Discover more
Croatian Prime Minister Tihomir Orešković opens Teva's new multi-purpose synthesis plant in Savski Marof.
How Our Uniqueness Creates Healthcare Confidence Around the world, people know that our ultimate goal is their health and well-being. Find out how we do it:
Around the world, people know that our ultimate goal is their health and well-being. Find out how we do it: